233 related articles for article (PubMed ID: 9768656)
1. Human growth hormone treatment of short-stature children born small for gestational age: effect on muscle and adipose tissue mass during a 3-year treatment period and after 1 year's withdrawal.
Leger J; Garel C; Fjellestad-Paulsen A; Hassan M; Czernichow P
J Clin Endocrinol Metab; 1998 Oct; 83(10):3512-6. PubMed ID: 9768656
[TBL] [Abstract][Full Text] [Related]
2. Muscle function improves during growth hormone therapy in short children born small for gestational age: results of a peripheral quantitative computed tomography study on body composition.
Schweizer R; Martin DD; Schönau E; Ranke MB
J Clin Endocrinol Metab; 2008 Aug; 93(8):2978-83. PubMed ID: 18505766
[TBL] [Abstract][Full Text] [Related]
3. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
4. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
de Zegher F; Du Caju MV; Heinrichs C; Maes M; De Schepper J; Craen M; Vanweser K; Malvaux P; Rosenfeld RG
J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
[TBL] [Abstract][Full Text] [Related]
5. Height, muscle, fat and bone response to growth hormone in short children with very low birth weight born appropriate for gestational age and small for gestational age.
Berndt C; Schweizer R; Ranke MB; Binder G; Martin DD
Horm Res Paediatr; 2014; 82(2):81-8. PubMed ID: 24969628
[TBL] [Abstract][Full Text] [Related]
6. Prevention of growth deceleration after withdrawal of growth hormone therapy in idiopathic short stature.
Lampit M; Hochberg Z
J Clin Endocrinol Metab; 2002 Aug; 87(8):3573-7. PubMed ID: 12161476
[TBL] [Abstract][Full Text] [Related]
7. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
Fjellestad-Paulsen A; Simon D; Czernichow P
J Clin Endocrinol Metab; 2004 Mar; 89(3):1234-9. PubMed ID: 15001616
[TBL] [Abstract][Full Text] [Related]
8. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
Sas T; Mulder P; Hokken-Koelega A
J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging evaluation of adipose tissue and muscle tissue mass in children with growth hormone (GH) deficiency, Turner's syndrome, and intrauterine growth retardation during the first year of treatment with GH.
Leger J; Carel C; Legrand I; Paulsen A; Hassan M; Czernichow P
J Clin Endocrinol Metab; 1994 Apr; 78(4):904-9. PubMed ID: 8157719
[TBL] [Abstract][Full Text] [Related]
10. Fat distribution in short-stature children born small for gestational age.
Maeyama T; Ida S; Onuma S; Shoji Y; Yamamoto T; Etani Y; Kawai M
Pediatr Int; 2020 Dec; 62(12):1351-1356. PubMed ID: 32521070
[TBL] [Abstract][Full Text] [Related]
11. Thyroid function in short children born small-for-gestational age (SGA) before and during GH treatment.
de Kort SW; Willemsen RH; van der Kaay DC; van Dijk M; Visser TJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2008 Aug; 69(2):318-22. PubMed ID: 18221400
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone-induced increases in skeletal muscle mass alleviates the associated insulin resistance in short children born small for gestational age, but not with growth hormone deficiency.
Martin DD; Schweizer R; Schönau E; Binder G; Ranke MB
Horm Res; 2009; 72(1):38-45. PubMed ID: 19571558
[TBL] [Abstract][Full Text] [Related]
13. First two years' response to growth hormone treatment in very young preterm small for gestational age children.
Garcia RA; Longui CA; Kochi C; Arruda M; Faria CD; Calliari LE; Monte O; Pachi PR; Saenger P
Horm Res; 2009; 72(5):275-80. PubMed ID: 19844113
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial.
Sas T; de Waal W; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
J Clin Endocrinol Metab; 1999 Sep; 84(9):3064-70. PubMed ID: 10487666
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
Lem AJ; van der Kaay DC; Hokken-Koelega AC
J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone treatment of short children born small for gestational age: growth responses with continuous and discontinuous regimens over 6 years.
de Zegher F; Albertsson-Wikland K; Wollmann HA; Chatelain P; Chaussain JL; Löfström A; Jonsson B; Rosenfeld RG
J Clin Endocrinol Metab; 2000 Aug; 85(8):2816-21. PubMed ID: 10946888
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone therapy in short children born small for gestational age: effects on abdominal fat partitioning and circulating follistatin and high-molecular-weight adiponectin.
Ibáñez L; Lopez-Bermejo A; Díaz M; Jaramillo A; Marín S; de Zegher F
J Clin Endocrinol Metab; 2010 May; 95(5):2234-9. PubMed ID: 20332245
[TBL] [Abstract][Full Text] [Related]
19. Head circumference and body proportions before and during growth hormone treatment in short children who were born small for gestational age.
Arends NJ; Boonstra VH; Hokken-Koelega AC
Pediatrics; 2004 Sep; 114(3):683-90. PubMed ID: 15342839
[TBL] [Abstract][Full Text] [Related]
20. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
